Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
500124
Company
DR.REDDY'S LABORATORIES LTD.
Exchange Disseminated Time
Completion of Audit of Company's formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA |
03/09/17 11:23
Dr Reddys Laboratories Ltd has informed BSE that the audit of Company's formulation manufacturing facilty at Duwada, Visakhapatnam, by the US FDA, has been completed on March 08, 2017. The Company have been issued a Form 483 with 13 observations, which the Company is addressing.
<< Back
Recently Viewed